Published in Sci Rep on March 27, 2017
A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem (1957) 173.99
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res (2010) 25.55
Rho GTPases in cell biology. Nature (2002) 22.81
Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol (2005) 16.77
Statin use and reduced cancer-related mortality. N Engl J Med (2012) 8.51
Protein prenylation: molecular mechanisms and functional consequences. Annu Rev Biochem (1996) 8.08
Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth. J Lipid Res (1980) 6.50
The Ras superfamily at a glance. J Cell Sci (2005) 4.83
GDIs: central regulatory molecules in Rho GTPase activation. Trends Cell Biol (2005) 4.13
Rho GTPases are over-expressed in human tumors. Int J Cancer (1999) 3.70
The association between statins and cancer incidence in a veterans population. J Natl Cancer Inst (2008) 3.40
The statins as anticancer agents. Clin Cancer Res (2003) 3.36
Rho-family GTPases: it's not only Rac and Rho (and I like it). J Cell Sci (2004) 3.27
Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts. J Clin Invest (2005) 2.89
HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis. Leukemia (2002) 2.89
RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype. Cancer Res (2000) 2.48
Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters. Br J Cancer (2002) 2.38
Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study. J Natl Cancer Inst (2011) 2.27
Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase. J Clin Invest (1980) 2.26
Rho GTPases have diverse effects on the organization of the actin filament system. Biochem J (2004) 2.23
Statins reduce the risk of lung cancer in humans: a large case-control study of US veterans. Chest (2007) 2.15
De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy. Br J Cancer (2009) 2.05
Acetate is a bioenergetic substrate for human glioblastoma and brain metastases. Cell (2014) 1.90
Acetate dependence of tumors. Cell (2014) 1.80
Rho proteins and cancer. Breast Cancer Res Treat (2004) 1.77
3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27(Kip1). J Biol Chem (1999) 1.76
Dysregulation of the mevalonate pathway promotes transformation. Proc Natl Acad Sci U S A (2010) 1.71
Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study. Carcinogenesis (2001) 1.67
Expression of seven main Rho family members in gastric carcinoma. Biochem Biophys Res Commun (2004) 1.63
Overexpression of RhoA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer. Clin Cancer Res (2004) 1.58
Mechanisms of statin-mediated inhibition of small G-protein function. J Biol Chem (2005) 1.52
Androgen axis in prostate cancer. J Cell Biochem (2006) 1.48
ATP-citrate lyase: a key player in cancer metabolism. Cancer Res (2012) 1.48
Hypocholesterolaemia in malignancy due to elevated low-density-lipoprotein-receptor activity in tumour cells: evidence from studies in patients with leukaemia. Lancet (1985) 1.46
Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer. Breast Cancer Res Treat (2010) 1.42
Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53. Oncogene (1998) 1.35
Human prostate cancer cells lack feedback regulation of low-density lipoprotein receptor and its regulator, SREBP2. Int J Cancer (2001) 1.34
Statin-induced breast cancer cell death: role of inducible nitric oxide and arginase-dependent pathways. Cancer Res (2007) 1.34
The Rho GTPase family: a Racs to Wrchs story. J Cell Sci (2002) 1.29
Motility-related proteins as markers for head and neck squamous cell cancer. Laryngoscope (2001) 1.28
Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells. Leukemia (2001) 1.27
Overexpression of RhoA mRNA is associated with advanced stage in testicular germ cell tumour. BJU Int (2001) 1.26
Cytotoxic effects of intra and extracellular zinc chelation on human breast cancer cells. Eur J Pharmacol (2006) 1.19
Cell motility as a prognostic factor in Stage I nonsmall cell lung carcinoma: the role of gelsolin expression. Cancer (1999) 1.18
Mitochondria and Cancer. Mol Cell (2016) 1.11
Lovastatin-induced up-regulation of the BH3-only protein, Bim, and cell death in glioblastoma cells. J Neurochem (2004) 1.10
Brevinin-2R(1) semi-selectively kills cancer cells by a distinct mechanism, which involves the lysosomal-mitochondrial death pathway. J Cell Mol Med (2008) 1.09
Exploiting the mevalonate pathway to distinguish statin-sensitive multiple myeloma. Blood (2010) 1.05
Statin-triggered cell death in primary human lung mesenchymal cells involves p53-PUMA and release of Smac and Omi but not cytochrome c. Biochim Biophys Acta (2010) 1.04
Statin-induced inhibition of MCF-7 breast cancer cell proliferation is related to cell cycle arrest and apoptotic and necrotic cell death mediated by an enhanced oxidative stress. Cancer Invest (2008) 1.03
Energy disruptors: rising stars in anticancer therapy? Oncogenesis (2016) 1.02
Effect of simvastatin on glioma cell proliferation, migration, and apoptosis. Neurosurgery (2009) 1.00
Apoptosis, autophagy and ER stress in mevalonate cascade inhibition-induced cell death of human atrial fibroblasts. Cell Death Dis (2012) 0.97
Determinants of sensitivity to lovastatin-induced apoptosis in multiple myeloma. Mol Cancer Ther (2007) 0.97
Survivin plays as a resistant factor against tamoxifen-induced apoptosis in human breast cancer cells. Breast Cancer Res Treat (2008) 0.96
RhoA is associated with invasion and lymph node metastasis in upper urinary tract cancer. BJU Int (2003) 0.96
Inhibition of protein geranylgeranylation induces apoptosis in myeloma plasma cells by reducing Mcl-1 protein levels. Blood (2003) 0.95
Role of BNIP3 in TNF-induced cell death--TNF upregulates BNIP3 expression. Biochim Biophys Acta (2009) 0.95
Identifying molecular features that distinguish fluvastatin-sensitive breast tumor cells. Breast Cancer Res Treat (2013) 0.91
Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease. Pharmacol Ther (2014) 0.90
Geranylgeranyl transferase 1 modulates autophagy and apoptosis in human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol (2011) 0.90
Simvastatin inhibits proliferation and induces apoptosis in human lung cancer cells. Oncol Res (2013) 0.89
Apoptotic induction by simvastatin in human lung cancer A549 cells via Akt signaling dependent down-regulation of survivin. Invest New Drugs (2010) 0.89
Airway mesenchymal cell death by mevalonate cascade inhibition: integration of autophagy, unfolded protein response and apoptosis focusing on Bcl2 family proteins. Biochim Biophys Acta (2014) 0.88
Choose your own path: specificity in Ras GTPase signaling. Mol Biosyst (2008) 0.87
The mevalonate cascade as a target to suppress extracellular matrix synthesis by human airway smooth muscle. Am J Respir Cell Mol Biol (2010) 0.87
Decreased feedback regulation of low density lipoprotein receptor activity by sterols in leukemic cells from patients with acute myelogenous leukemia. J Lipid Res (1997) 0.86
Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathway. Oncotarget (2016) 0.86
Overexpression of Rac-1 small GTPase binding protein in oral squamous cell carcinoma. J Oral Maxillofac Surg (2004) 0.85
Lovastatin inhibits VEGFR and AKT activation: synergistic cytotoxicity in combination with VEGFR inhibitors. PLoS One (2010) 0.84
Atorvastatin activates heme oxygenase-1 at the stress response elements. J Cell Mol Med (2012) 0.84
Neuronal chemorepellent Semaphorin 3E inhibits human airway smooth muscle cell proliferation and migration. J Allergy Clin Immunol (2013) 0.84
Statin use and survival following glioblastoma multiforme. Cancer Epidemiol (2014) 0.84
Inhibition of geranylgeranylation mediates sensitivity to CHOP-induced cell death of DLBCL cell lines. Exp Cell Res (2011) 0.84
Simvastatin potentiates tumor necrosis factor alpha-mediated apoptosis of human vascular endothelial cells via the inhibition of the geranylgeranylation of RhoA. Life Sci (2006) 0.83
Rac2 expression and mutation in human brain tumors. Acta Neurochir (Wien) (2005) 0.83
Synergistic induction of apoptosis by sulindac and simvastatin in A549 human lung cancer cells via reactive oxygen species-dependent mitochondrial dysfunction. Int J Oncol (2013) 0.82
Autophagy regulates trans fatty acid-mediated apoptosis in primary cardiac myofibroblasts. Biochim Biophys Acta (2012) 0.81
Simvastatin enhances irinotecan-induced apoptosis in human non-small cell lung cancer cells by inhibition of proteasome activity. Invest New Drugs (2010) 0.81
Reduction in cholesterol synthesis in response to serum starvation in lymphoblasts of a patient with Barth syndrome. Biochem Cell Biol (2010) 0.79
Geranylgeranylation but not GTP loading determines rho migratory function in T cells. J Immunol (2007) 0.79
Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer. Sci Rep (2016) 0.78
Enhanced apoptosis by pemetrexed and simvastatin in malignant mesothelioma and lung cancer cells by reactive oxygen species-dependent mitochondrial dysfunction and Bim induction. Int J Oncol (2014) 0.77
Synergistic effects of combined treatment with simvastatin and exemestane on MCF-7 human breast cancer cells. Mol Med Rep (2015) 0.77
The potential of the mevalonate pathway for enhanced isoprenoid production. Biotechnol Adv (2016) 0.76
Geranylgeranylation but not GTP-loading of Rho GTPases determines T cell function. Sci Signal (2008) 0.76
Leukocytes Crossing the Endothelium: A Matter of Communication. Int Rev Cell Mol Biol (2016) 0.76
Human induced pluripotent stem cell differentiation and direct transdifferentiation into corneal epithelial-like cells. Oncotarget (2016) 0.76
Could drugs inhibiting the mevalonate pathway also target cancer stem cells? Drug Resist Updat (2016) 0.76
Molecular mechanism underlying the anticancer effect of simvastatin on MDA-MB-231 human breast cancer cells. Mol Med Rep (2015) 0.75
A conserved MADS-box phosphorylation motif regulates differentiation and mitochondrial function in skeletal, cardiac, and smooth muscle cells. Cell Death Dis (2015) 0.75